Lindis Biotech GmbH
Records under this name other than the patents Lindis Biotech GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 2 of 2 · Back to Lindis Biotech GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,071,158 | Combination of the Application of Antibodies for Immunostimulation Together with Glucocorticoids Term ended Term ended Apr 26, 2025 · High confidence | Term ended | Term ended Apr 26, 2025 | High confidence |
| US 10,576,149 | Combination Of The Application Of Antibodies For Immunostimulation Together With Glucocorticoids Term ended Term ended Apr 26, 2025 · High confidence | Term ended | Term ended Apr 26, 2025 | High confidence |